Long-term expression of metabolism-associated genes in the rat hippocampus following recurrent neonatal seizures and its regulation by melatonin

Ni,Hong; Sun,Qi; Tian,Tian; Feng,Xing; Sun,Bao‑Liang

doi:10.3892/mmr.2015.3691

Long-term expression of metabolism-associated genes in the rat hippocampus following recurrent neonatal seizures and its regulation by melatonin

Authors:
- Hong Ni
- Qi Sun
- Tian Tian
- Xing Feng
- Bao‑Liang Sun
View Affiliations

Affiliations: Neurology Laboratory, Institute of Pediatrics, Children's Hospital of Soochow University, Suzhou, Jiangsu 215003, P.R. China, Department of Neurology, Key Laboratory of Cerebral Microcirculation, University of Shandong, Affiliated Hospital of Taishan Medical College, Taian, Shandong 271000, P.R. China
Published online on: April 28, 2015 https://doi.org/10.3892/mmr.2015.3691
Pages: 2727-2734

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Despite the effective use of antiepileptic drugs (AEDs) for epilepsy, therapeutic failure occurs in 30% of patients. Novel approaches are targeting the inhibition of epileptogenesis. N‑acetyl‑5‑methoxytryptamine (melatonin) is an indoleamine produced mainly by the pineal gland, and has been observed to exhibit antiepileptic and neuroprotective effects in experimental and clinical investigations. In the present study, the underlying protective mechanism of melatonin on neonatal seizure‑induced long‑term excitotoxicity was examined in the hippocampus of rats, predominantly on the metabolism‑associated genes. Sprague Dawley rats (6‑day‑old; P6) were randomly divided into four groups, the control (Cont), melatonin‑treated control (Mel), recurrent neonatal seizure (RS) and treatment with melatonin and RS combined (Mel+RS). At P35, mossy fiber sprouting and changes in gene expression in hippocampus were assessed using Timm staining, reverse transcription‑quantitative polymerase chain reaction and use of the 2‑ΔCT methods, respectively. The aberrant mossy fiber sprouting in the supra granular region of the dentate gyrus and CA3 subfield of the hippocampus was suppressed by pretreatment with melatonin. In addition, among the nineteen genes identified, four energy metabolism‑associated genes (Kcnj11, leptin receptor, dopamine receptor D2 and melanocortin 4 receptor), four lipid metabolism‑associated genes (apolipoprotein A‑I, opioid receptor κ 1, pyruvate dehydrogenase kinase, isozyme 4 and cytochrome P450, family 46, subfamily a, polypeptide 1) and zinc transporter 1 (ZnT1), sphingomyelinase (nSMase) and Cathepsin‑E, were markedly downregulated by melatonin treatment in the Mel group or in the developmental seizure RS and Mel+RS groups, compared with that in the Cont group. Furthermore, the melatonin‑pretreated seizure rats (Mel+RS) exhibited a significantly upregulated expression of calcium/calmodulin‑dependent protein kinase II α (CaMKIIα), acetyl‑Coenzyme A acetyltransferase 1 (ACAT1), ZnT‑1, metallothionein 1 (MT‑1), nSMase and Cathepsin‑E, compared with the RS rats. Thus, the present study investigated changes in the expression of metabolic genes in the hippocampus following pretreatment with melatonin. Fluorthyl‑induced decreases in the expression levels of ACAT1/nSMase/Cathepsin‑E, ZnT‑1/MT‑1 and CaMKIIα in the hippocampus, and the reversal by melatonin may be associated with a decrease in neonatal seizure‑induced aberrant mossy fiber sprouting, which requires further investigation.

View Figures

View References

1	Tolaymat A, Nayak A, Geyer JD, Geyer SK and Carney PR: Diagnosis and management of childhood epilepsy. Curr Probl Pediatr Adolesc Health Care. 45:3–17. 2015. View Article : Google Scholar : PubMed/NCBI
2	Anovadiya AP, Sanmukhani JJ and Tripathi CB: Epilepsy: Novel therapeutic targets. J Pharmacol Pharmacother. 3:112–117. 2012.PubMed/NCBI
3	Banach M, Gurdziel E, Jędrych M and Borowicz KK: Melatonin in experimental seizures and epilepsy. Pharmacol Rep. 63:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
4	Uberos J, Augustin-Morales MC, Molina Carballo A, Florido J, Narbona E and Muñoz-Hoyos A: Normalization of the sleep-wake pattern and melatonin and 6-sulphatoxy-melatonin levels after a therapeutic trial with melatonin in children with severe epilepsy. J Pineal Res. 50:192–196. 2011.
5	Banach M, Gurdziel E, Jedrych M and Borowicz KK: Melatonin in experimental seizures and epilepsy. Pharmacol Rep. 63:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
6	Jain S and Besag FM: Does melatonin affect epileptic seizures? Drug Saf. 36:207–215. 2013. View Article : Google Scholar : PubMed/NCBI
7	Ardura J, Andres J, Garmendia JR and Ardura F: Melatonin in epilepsy and febrile seizures. J Child Neurol. 25:888–891. 2010. View Article : Google Scholar : PubMed/NCBI
8	Paprocka J, Dec R, Jamroz E and Marszał E: Melatonin and childhood refractory epilepsy-a pilot study. Med Sci Monit. 16:CR389–396. 2010.PubMed/NCBI
9	Goldberg-Stern H, Oren H, Peled N and Garty BZ: Effect of melatonin on seizure frequency in intractable epilepsy: A pilot study. J Child Neurol. 27:1524–1528. 2012. View Article : Google Scholar : PubMed/NCBI
10	Sheldon SH: Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet. 351:12541998. View Article : Google Scholar : PubMed/NCBI
11	Banach M, Gurdziel E, Jedrych M and Borowicz KK: Melatonin in experimental seizures and epilepsy. Pharmacol Rep. 63:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
12	Musshoff U and Speckmann EJ: Diurnal actions of melatonin on epileptic activity in hippocampal slices of rats. Life Sci. 73:2603–2610. 2003. View Article : Google Scholar : PubMed/NCBI
13	Forcelli PA, Soper C, Duckles A, Gale K and Kondratyev A: Melatonin potentiates the anticonvulsant action of phenobarbital in neonatal rats. Epilepsy Res. 107:217–223. 2013. View Article : Google Scholar : PubMed/NCBI
14	Ni H, Jiang YW, Xiao ZJ, Tao LY, Jin MF and Wu XR: Dynamic pattern of gene expression of ZnT-1, ZnT-3 and PRG-1 in rat brain following flurothyl-induced recurrent neonatal seizures. Toxico Lett. 194:86–93. 2010. View Article : Google Scholar
15	Ni H, Ren SY and Zhang LL: Expression profiles of hippocampal regenerative sprouting-related genes and their regulation byE-64 d in a developmental rat model of penicillin-induced recurrent epilepticus. Toxico Lett. 217:162–169. 2013. View Article : Google Scholar
16	Ni H, Yan JZ, Zhang LL, Feng X and Wu XR: Long-term effects of recurrent neonatal seizures on neurobehavioral function and related gene expression and its intervention by inhibitor of cathepsin B. Neurochem Res. 37:31–39. 2012. View Article : Google Scholar
17	Moezi L, Shafaroodi H, Hojati A and Dehpour AR: The interaction of melatonin and agmatine on pentylenetetrazole-induced seizure threshold in mice. Epilepsy Behav. 22:200–206. 2011. View Article : Google Scholar : PubMed/NCBI
18	Mareš J, Pometlová M, Deykun K, Krýsl D and Rokyta R: An isolated epileptic seizure elicits learning impairment which could be prevented by melatonin. Epilepsy Behav. 23:199–204. 2012. View Article : Google Scholar
19	Ni H, Jiang YW, Tao LY, Cen JN and Wu XR: Effects of penicillin-induced developmental epilepticus on hippocampal regenerative sprouting, related gene expression and cognitive deficits in rats. Toxico Lett. 188:161–166. 2009. View Article : Google Scholar
20	Johnson MR, Wang K, Smith JB, Heslin MJ and Diasio RB: Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem. 278:175–184. 2000. View Article : Google Scholar : PubMed/NCBI
21	Tian Y, Yabuki Y, Moriguchi S, Fukunaga K, Mao PJ and Hong LJ: Melatonin reverses the decreases in hippocampal protein serine/threonine kinases observed in an animal model of autism. J Pineal Res. 56:1–11. 2014. View Article : Google Scholar
22	Koh PO: Melatonin regulates the calcium-buffering proteins, parvalbumin and hippocalcin, in ischemic brain injury. J Pineal Res. 53:358–365. 2012. View Article : Google Scholar : PubMed/NCBI
23	Cetinkaya M, Alkan T, Ozyener F, Kafa IM, Kurt MA and Koksal N: Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology. 99:302–310. 2011. View Article : Google Scholar
24	Sánchez-Barceló EJ, Mediavilla MD and Reiter RJ: Clinical uses of melatonin in pediatrics. Int J Pediatr. 2011:8926242011. View Article : Google Scholar : PubMed/NCBI
25	Zamorskii II, Sopova IY and Khavinson VKh: Effects of melatonin and epithalamin on the content of protein and lipid peroxidation products in rat cortex and hippocampus under conditions of acute hypoxia. Bull Exp Biol Med. 154:51–53. 2012. View Article : Google Scholar
26	Tchekalarova J, Petkova Z, Pechlivanova D, Moyanova S, Kortenska L and Mitreva R: Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage and behavioral changes in a kainate model of temporal lobe epilepsy. Epilepsy Behav. 27:174–187. 2013. View Article : Google Scholar : PubMed/NCBI
27	Jain A, Sharma D, Suhalka P, Sukhwal P and Bhatnagar M: Changes in the density of nitrergic neurons in the hippocampus of rats following kainic acid and melatonin administration. Physiol Res. 62:197–203. 2013.
28	Mareš J, Stopka P, Nohejlová K and Rokyta R: Oxidative stress induced by epileptic seizure and its attenuation by melatonin. Physiol Res. 62(Suppl 1): 67–74. 2013.
29	Atanasova M, Petkova Z, Pechlivanova D, Dragomirova P, Blazhev A and Tchekalarova J: Strain-dependent effects of long-term treatment with melatonin on kainic acid-induced status epilepticus, oxidative stress and the expression of heat shock proteins. Pharmacol Biochem Behav. 111:44–50. 2013. View Article : Google Scholar : PubMed/NCBI
30	Ni H, Jiang YW, Tao LY, Jin MF and Wu XR: ZnT-1, ZnT-3, CaMK II, PRG-1 expressions in hippocampus following neonatal seizure-induced cognitive deficit in rats. Toxicol Lett. 184:145–150. 2009. View Article : Google Scholar
31	Adibhatla RM and Hatcher JF: Altered lipid metabolism in brain injury and disorders. Subcell Biochem. 49:241–268. 2008.PubMed/NCBI
32	McNally MA and Hartman AL: Ketone bodies in epilepsy. J Neurochem. 121:28–35. 2012. View Article : Google Scholar : PubMed/NCBI
33	Zaidi N, Hermann C, Herrmann T and Kalbacher H: Emerging functional roles of cathepsin E. Biochem Biophys Res Commun. 377:327–330. 2008. View Article : Google Scholar : PubMed/NCBI
34	Bernstein HG and Wiederanders B: An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains. Brain Res. 667:287–290. 1994. View Article : Google Scholar : PubMed/NCBI
35	Tominaga K, Nakanishi H, Yasuda Y and Yamamoto K: Excitotoxin-induced neuronal death is associated with response of a unique intracellular aspartic proteinase, cathepsin E. J Neurochem. 71:2574–2584. 1998. View Article : Google Scholar : PubMed/NCBI
36	Chihara M, Nomura T, Tachibana M, Nomura H, Nomura Y and Hagino Y: Effects of exogenous phospholipase enzymes, arachidonic acid and 1-oleoyl-2-acetyl-sn-glycerol on ketogenesis in isolated rat hepatocytes. Biochim Biophys Acta. 1012:5–9. 1989. View Article : Google Scholar : PubMed/NCBI
37	Farooqui AA, Horrocks LA and Farooqui T: Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide. J Neurosci Res. 85:1834–1850. 2007. View Article : Google Scholar : PubMed/NCBI
38	Ruiz N, Pacheco LF, Farrell B, Cox CB, Ermolinsky BS, Garrido-Sanabria ER and Nair S: Metabolic gene expression changes in the hippocampus of obese epileptic male rats in the pilocarpine model of temporal lobe epilepsy. Brain Res. 1426:86–95. 2011. View Article : Google Scholar : PubMed/NCBI
39	Koster JC, Cadario F, Peruzzi C, Colombo C, Nichols CG and Barbetti F: The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. J Clin Endocrinol Metab. 93:1054–1061. 2008. View Article : Google Scholar
40	Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S and Inagaki N: Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science. 292:1543–1546. 2001. View Article : Google Scholar : PubMed/NCBI
41	Liu ZL, He B, Fang F, Tang CY and Zou LP: Analysis of single nucleotide polymorphisms in the melanocortin-4 receptor promoter in infantile spasms. Neuropediatrics. 38:304–309. 2007. View Article : Google Scholar
42	Dunleavy M, Provenzano G, Henshall DC and Bozzi Y: Kainic acid-induced seizures modulate Akt (SER473) phosphorylation in the hippocampus of dopamine D2 receptor knockout mice. J Mol Neurosci. 49:202–210. 2013. View Article : Google Scholar :
43	Jayaram B, Khan RS, Kastin AJ, Hsuchou H, Wu X and Pan W: Role of astrocytic leptin signaling against excitotoxicity. J Mol Neurosci. 49:523–530. 2013. View Article : Google Scholar :
44	Ueda Y, Kitamoto A, Willmore LJ and Kojima T: Hippocampal gene expression profiling in a rat model of posttraumatic epilepsy reveals temporal upregulation of lipid metabolism-related genes. Neurochem Res. 38:1399–1406. 2013. View Article : Google Scholar : PubMed/NCBI